In Vitro Toxicity Testing Market

In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025

Report Code: BT 2373 Aug, 2020, by marketsandmarkets.com

[354 Pages Report] The in vitro toxicology testing market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Growth in this market is driven majorly by the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development.

In Vitro Toxicity Testing Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global In Vitro Toxicology Testing Market

According to our findings, the in vitro toxicology market is expected to grow at an approximately CAGR of 9.0%-11.0% for next two years. According to our analysis, the below factors are playing a key role in shaping the growth of the global market;

  • With the increase in demand for faster testing and research being conducted in the field, the demand for in vitro toxicology technologies has also increased, especially diagnostic assays and PCR. The FDA has approved various in vitro diagnostic kits such as In vitro diagnostic assays and PCR testing panels and drugs for emergency use in COVID -19 testing and diagnostics.
  • The outbreak of COVID-19 has been increasing at an exponential level in the US. This has led to a decline in regular patient visits to hospitals and clinics and has also led to a decline in the number of profiling studies being conducted under normal circumstances. This is expected to inhibit market growth to a certain extent.
  • Due to the rapid spread of COVID-19, the medical supplies and equipment are at the risk of supply shortage, due to the temporary lockdown of manufacturing sites in areas affected by COVID-19 or travel restrictions impacting shipments. Beyond transportation-related delays arising from travel restrictions and some driver shortage issues, COVID-19 hasn’t hugely impacted supplies of raw materials for in vitro toxicology technologies.
  • The normalization of the global economy will slowly increase the diagnostic procedures kept on hold of or other pipeline drugs, which will, in turn, lead to market growth from the first quarter of 2021.

In Vitro Toxiocolgy Testing Market Dynamics

Driver: Opposition to animal testing

Animal testing is a highly time-consuming process and involves high costs and immense safety risks for the animals involved. Working with rodent and rabbit models also increases the risk of zoonotic diseases. In 2004, the European Union passed legislation that prohibited the testing of finished cosmetic products on animals. It would be followed by a ban on testing cosmetic ingredients on animals in the European Union in 2009. This was further amended by forbidding the marketing of cosmetic products tested on animals. Complex toxicological endpoints, such as repeated-dose toxicity, reproductive toxicity, and toxicokinetics, were exempted from this ban.

Restraint: Reluctance of Regulatory authorities to consider alternative methods for proving safety and efficacy

There has been an increasing focus on the development and use of non-animal-based testing methods across a number of industries. Regulatory agencies can opt for validated alternative tests over in vivo tests. Under such circumstances, in vitro methods need to prove their superiority over animal methods in terms of safety and efficacy. However, a number of countries have shown reluctance to using in vitro testing over in vivo methods, even after the assay has proven its superior scientific relevance. A number of regulatory agencies in the US continue to use data obtained from animal tests. Many agencies use in vivo methods for evaluating new toxicology test methods. The results acquired from new alternative methods are compared qualitatively to the results obtained from animal tests.

Opportunity: Increasing focus on drug discovery and personalized medicine using in vitro methods

Over the years, there has been a definite decline in the pharmaceutical industry’s productivity due to increasing development costs and the decreasing profitability of new medical entities (NMEs) launched (Source: Tufts Center for the Study of Drug Development). One of the greatest challenges faced by the pharmaceutical industry today is the failure of promising new drug candidates due to adverse effects discovered during preclinical animal safety studies and clinical trials. The development of techniques to show or predict efficacy and toxicity in humans, before drugs move to clinical trials, could greatly help lower the failure rate of new medications.

Challenge: Derth of skilled professionals

IVT comprises sophisticated methods to study biological entities within a laboratory setup. It involves labor-intensive techniques to perform experiments and requires skilled professionals such as researchers and technicians to set up and run tests and experiments, make observations, obtain results, and analyze data. A lack of knowledge regarding the underlying scientific principles and the right choice of technique may result in several direct and indirect expenses and, thereby, increase the workload and time pressure on researchers and service providers. Thus, there is a need for highly skilled personnel for method development, validation, operation, and troubleshooting activities.

The consumables segment is expected to account for the largest share of the in vitro toxicology testing market in 2019

Consumables are expected to be the largest revenue contributor to the in vitro toxicology testing market in 2019. The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.

The organ toxicity segment is expected to grow at a high CAGR

The toxicity endpoints and tests market, includes ADME; skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other toxicity endpoints & tests. The organ toxicity segment is expected to grow at the highest CAGR during the forecast period due to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.

The cell culture technologies segment is expected to account for the largest share of the in vitro toxicology technologies market in 2019

The cell culture technologies segment accounted for the largest share of the market in 2019. This is attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.

In Vitro Toxicity Testing Market  by Region

To know about the assumptions considered for the study, download the pdf brochure

Asia Pacific is expected to grow at the highest rate in the in vitro toxicology testing market in 2019

The in vitro toxicology testing market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is due to the emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety, all of which are driving adoption of in vitro toxicology testing in the Asia Pacific.

Key Market Players

The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2018

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product & Service, Technology, Toxicity Endpoint & Test, Industry, Method, and Region

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa

Companies covered

Thermo Fisher Scientific Inc. (US), Eurofins Scientific SE (Luxembourg), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), BioRad Laboratories, QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US), Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and Insphero (Switzerland).

In Vitro Toxicity Testing Market, by Product & Service

  • Covid Impact,By Product & Service
  • Consumables
  • Assays
    • Bacterial Toxicity Assays
    • Enzyme Toxicity Assays
    • Cell-based Elisa & Western Blots
    • Receptor-binding Assays
    • Tissue Culture Assays
    • Other Assays
  • Equipment
  • Software
  • Services

In Vitro Toxicity Testing Market, by Method

  • Cellular Assays 
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

In Vitro Toxicity Testing Market, by Toxicity Endpoint & Test

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

In Vitro Toxicity Testing Market, by Industry

  • Covid Impact,By Industry
  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

In Vitro Toxicity Testing Market, by Technology

  • Cell Culture Technologies 
  • High-throughput Technologies 
  • Toxicogenomics

In Vitro Toxicity Testing Market, by Region

  • Covid Impact,By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In August 2019, Covance launched a laboratory solution within its functional service provider (FSPx) offering, comprising a clinical analytics service and clinical operations capabilities.
  • In May 2018, Eurofins opened a new food testing laboratory in Suzhou, China with an investment of USD million (EUR 3 million) to expand its presence in the Asia Pacific.
  • In August 2019, Merck acquired BSSN Software, a German laboratory informatics company for ease of data integration, collaboration, analysis, and long-term archiving in laboratories.
  • In September 2019, Covance opened a new R&D Center in Shanghai, China.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 42)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 STAKEHOLDERS
    1.5 LIMITATIONS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 46)
    2.1 RESEARCH APPROACH
           FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primaries
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH
           FIGURE 4 MARKET SIZE APPROACH
           FIGURE 5 BOTTOM-UP APPROACH
    2.3 DATA TRIANGULATION APPROACH
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 54)
    FIGURE 7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020 VS. 2025 (USD MILLION)
    FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
    FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020 VS. 2025 (USD MILLION)
    FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020 VS. 2025 (USD MILLION)
    FIGURE 12 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. - 59)
    4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
           FIGURE 13 OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH
    4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
           FIGURE 14 CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2019
    4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 15 CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
    4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2018–2025)
           FIGURE 16 EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2025
    4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
           FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 64)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Opposition to animal testing
                    5.2.1.2 Technological advancements
                    5.2.1.3 R&D on early-stage toxicity detection
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy
                    5.2.2.2 Failure to establish the intricacies of in vivo conditions
                    5.2.2.3 Lack of in vitro models to study complex endpoints
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods
                    5.2.3.2 Increasing number of toxicology databases
           5.2.4 MARKET CHALLENGES
                    5.2.4.1 Dearth of skilled professionals

6 INDUSTRY INSIGHTS (Page No. - 71)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
    6.3 SUPPLY CHAIN ANALYSIS
           FIGURE 19 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
    6.4 REGULATORY COMMITTEE ACTIVITIES
           6.4.1 MAJOR STAKEHOLDERS
           6.4.2 KEY INFLUENCERS
    6.5 COVID-19 IMPACT ON THE IN VITRO TOXICOLOGY MARKET
           FIGURE 20 IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET

7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE (Page No. - 76)
    7.1 INTRODUCTION
    7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE
           FIGURE 21 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
           TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
           TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
    7.3 CONSUMABLES
           7.3.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
                    TABLE 3 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    7.4 ASSAYS
           TABLE 5 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,  2017–2019 (USD MILLION)
           TABLE 6 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
           TABLE 7 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
           TABLE 8 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           7.4.1 BACTERIAL TOXICITY ASSAYS
                    7.4.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries
                               TABLE 9 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                               TABLE 10 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           7.4.2 ENZYME TOXICITY ASSAYS
                    7.4.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies—a key factor driving market growth
                               TABLE 11 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                               TABLE 12 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           7.4.3 CELL-BASED ELISA & WESTERN BLOTS
                    7.4.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery
                               TABLE 13 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                               TABLE 14 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           7.4.4 RECEPTOR-BINDING ASSAYS
                    7.4.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products
                               TABLE 15 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                               TABLE 16 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           7.4.5 TISSUE CULTURE ASSAYS
                    7.4.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture
                               TABLE 17 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                               TABLE 18 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
           7.4.6 OTHER ASSAYS
                    TABLE 19 OTHER ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 20 OTHER ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    7.5 EQUIPMENT
           7.5.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH
                    TABLE 21 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 22 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    7.6 SOFTWARE
           7.6.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS
                    TABLE 23 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 24 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    7.7 SERVICES
           7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
                    TABLE 25 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 26 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2020–2025 (USD MILLION)

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST (Page No. - 99)
    8.1 INTRODUCTION
           FIGURE 22 ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
           TABLE 27 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
           TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
    8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
           8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
                    TABLE 29 ADME TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 30 ADME TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
           8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY
                    TABLE 31 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.4 GENOTOXICITY TESTING
           8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT— A KEY DRIVER FOR MARKET GROWTH
                    TABLE 33 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 34 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.5 CYTOTOXICITY TESTING
           8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET
                    TABLE 35 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 36 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.6 OCULAR TOXICITY TESTING
           8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
                    TABLE 37 OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 38 OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.7 ORGAN TOXICITY TESTING
           8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
                    TABLE 39 ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 40 ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.8 PHOTOTOXICITY TESTING
           8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
                    TABLE 41 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 42 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.9 DERMAL TOXICITY TESTING
           8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS
                    TABLE 43 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 44 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    8.10 OTHER TOXICITY ENDPOINTS & TESTS
           TABLE 45 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
           TABLE 46 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2020–2025 (USD MILLION)

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY (Page No. - 118)
    9.1 INTRODUCTION
           FIGURE 23 TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
           TABLE 47 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
           TABLE 48 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
    9.2 CELL CULTURE TECHNOLOGIES
           9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING
                    TABLE 49 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 50 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2020–2025 (USD MILLION)
    9.3 HIGH-THROUGHPUT TECHNOLOGIES
           9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH
                    TABLE 51 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 52 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2020–2025 (USD MILLION)
    9.4 TOXICOGENOMICS
           9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS
                    TABLE 53 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2017–2019 (USD MILLION)
                    TABLE 54 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2020–2025 (USD MILLION)

10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY (Page No. - 127)
     10.1 INTRODUCTION
               FIGURE 24 PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
               TABLE 55 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
               TABLE 56 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
     10.2 COVID-19 IMPACT, BY INDUSTRY
     10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS
             10.3.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT
                       TABLE 57 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 58 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
     10.4 COSMETICS & HOUSEHOLD PRODUCTS
             10.4.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
                       TABLE 59 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 60 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
     10.5 FOOD
             10.5.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH
                       TABLE 61 TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY
                       TABLE 62 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 63 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
     10.6 CHEMICALS
             10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET
                       TABLE 64 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 65 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)

11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD (Page No. - 139)
     11.1 INTRODUCTION
               FIGURE 25 IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
               TABLE 66 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
               TABLE 67 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
     11.2 CELLULAR ASSAYS
             11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
                       TABLE 68 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 69 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2020–2025 (USD MILLION)
     11.3 BIOCHEMICAL ASSAYS
             11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES
                       TABLE 70 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 71 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2020–2025 (USD MILLION)
     11.4 IN SILICO MODELS
             11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
                       TABLE 72 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 73 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2020–2025 (USD MILLION)
     11.5 EX-VIVO MODELS
             11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY
                       TABLE 74 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2017–2019 (USD MILLION)
                       TABLE 75 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2020–2025 (USD MILLION)

12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (Page No. - 149)
     12.1 INTRODUCTION
     12.2 COVID-19 IMPACT, BY REGION
               FIGURE 26 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2019)
               TABLE 76 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2017–2019 (USD MILLION)
               TABLE 77 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2020–2025 (USD MILLION)
     12.3 EUROPE
               FIGURE 27 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
               TABLE 78 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
               TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
               TABLE 80 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
               TABLE 81 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
               TABLE 82 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
               TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
               TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
               TABLE 85 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
               TABLE 86 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
               TABLE 87 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
               TABLE 88 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
               TABLE 89 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
               TABLE 90 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024(USD MILLION)
               TABLE 91 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.3.1 GERMANY
                       12.3.1.1 Germany holds the largest share of the European market
                                   TABLE 92 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 94 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 97 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 98 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 99 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 100 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 101 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 102 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 103 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.3.2 UK
                       12.3.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK
                                   TABLE 104 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 106 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 108 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 109 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 110 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 111 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 112 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 113 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 114 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 115 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.3.3 FRANCE
                       12.3.3.1 Research initiatives supported by the government are aiding market growth in France
                                   TABLE 116 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 118 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 119 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 120 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 121 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 122 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 123 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 124 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 125 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 126 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 127 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.3.4 ITALY
                       12.3.4.1 Growth in this market is mainly driven by the increasing life science R&D
                                   TABLE 128 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 129 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 130 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 131 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 132 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 133 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 134 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 135 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 136 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 137 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 138 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 139 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.3.5 SPAIN
                       12.3.5.1 Spain’s growing chemical industry is a major factor supporting the in vitro toxicology testing market in the country
                                   TABLE 140 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 141 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 142 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 143 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 144 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 145 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 146 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 147 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 148 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 149 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 150 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 151 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.3.6 REST OF EUROPE
                       TABLE 152 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                       TABLE 153 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                       TABLE 154 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                       TABLE 155 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                       TABLE 156 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                       TABLE 157 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                       TABLE 158 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                       TABLE 159 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                       TABLE 160 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                       TABLE 161 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                       TABLE 162 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                       TABLE 163 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
     12.4 NORTH AMERICA
               FIGURE 28 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017
               FIGURE 29 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
               TABLE 164 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
               TABLE 165 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
               TABLE 166 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
               TABLE 167 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
               TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
               TABLE 169 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
               TABLE 170 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
               TABLE 171 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
               TABLE 172 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
               TABLE 173 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
               TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
               TABLE 175 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
               TABLE 176 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
               TABLE 177 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.4.1 US
                       12.4.1.1 The US dominates the North American in vitro toxicology testing market due to a growing focus on biomarker discovery and research in the field of structure-based drug design
                                   TABLE 178 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 179 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 180 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 181 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 182 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 183 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 184 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 185 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 186 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 187 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 188 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 189 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.4.2 CANADA
                       12.4.2.1 Strong support for R&D and focus on developing new therapies will support market growth in Canada
                                   TABLE 190 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 191 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 192 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 193 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 194 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 195 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 196 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 197 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 198 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                                   TABLE 199 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 200 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 201 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
     12.5 ASIA PACIFIC
               FIGURE 30 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
               TABLE 202 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
               TABLE 203 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
               TABLE 204 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
               TABLE 205 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
               TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
               TABLE 207 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
               TABLE 208 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
               TABLE 209 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
               TABLE 210 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
               TABLE 211 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
               TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
               TABLE 213 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
               TABLE 214 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
               TABLE 215 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.5.1 CHINA
                       12.5.1.1 Increasing international pressure to ban animal testing methods will propel market growth in the coming years
                                   TABLE 216 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 217 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 218 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 219 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 220 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 221 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 222 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 223 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 224 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
                                   TABLE 225 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 226 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 227 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.5.2 JAPAN
                       12.5.2.1 Use of artificial skin patches and plates of cultured human cells has increased in Japan
                                   TABLE 228 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 229 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 230 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 231 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 232 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 233 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 234 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 235 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 236 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
                                   TABLE 237 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 238 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
                                   TABLE 239 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.5.3 INDIA
                       12.5.3.1 Growing CRAMs industry and the ban on the use of animals in cosmetics and universities are likely to propel market growth
                                   TABLE 240 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                                   TABLE 241 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                                   TABLE 242 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                                   TABLE 243 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                                   TABLE 244 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                                   TABLE 245 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                                   TABLE 246 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                                   TABLE 247 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                                   TABLE 248 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,  2017–2019 (USD MILLION)
                                   TABLE 249 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                                   TABLE 250 INDIA: IN VITRO TRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                                   TABLE 251 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
             12.5.4 REST OF ASIA PACIFIC
                       TABLE 252 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                       TABLE 253 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                       TABLE 254 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                       TABLE 255 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                       TABLE 256 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                       TABLE 257 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                       TABLE 258 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                       TABLE 259 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                       TABLE 260 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                       TABLE 261 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                       TABLE 262 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                       TABLE 263 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
     12.6 LATIN AMERICA
             12.6.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA A POPULAR OUTSOURCING MARKET
                       TABLE 264 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                       TABLE 265 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                       TABLE 266 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                       TABLE 267 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                       TABLE 268 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                       TABLE 269 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                       TABLE 270 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                       TABLE 271 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                       TABLE 272 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                       TABLE 273 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                       TABLE 274 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                       TABLE 275 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)
     12.7 MIDDLE EAST & AFRICA
             12.7.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
                       TABLE 276 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION)
                       TABLE 277 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
                       TABLE 278 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION)
                       TABLE 279 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION)
                       TABLE 280 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION)
                       TABLE 281 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION)
                       TABLE 282 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION)
                       TABLE 283 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
                       TABLE 284 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION)
                       TABLE 285 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION)
                       TABLE 286 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION)
                       TABLE 287 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION)

13 COMPETITIVE LANDSCAPE (Page No. - 257)
     13.1 OVERVIEW
               FIGURE 31 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO JUNE 2020
     13.2 MARKET SHARE ANALYSIS
               FIGURE 32 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2018
     13.3 COMPETITIVE LEADERSHIP MAPPING
               13.3.1 VISIONARY LEADERS
             13.3.2 INNOVATORS
             13.3.3 DYNAMIC DIFFERENTIATORS
             13.3.4 EMERGING COMPANIES
                       FIGURE 33 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
     13.4 COMPETITIVE SITUATION AND TRENDS
             13.4.1 PRODUCT & SERVICE LAUNCHES
                       TABLE 288 PRODUCT & SERVICE LAUNCHES, 2017–2020
             13.4.2 EXPANSIONS
                       TABLE 289 EXPANSIONS, 2017–2020
             13.4.3 ACQUISITIONS
                       TABLE 290 ACQUISITIONS, 2017–2020
             13.4.4 OTHER STRATEGIES
                       TABLE 291 OTHER STRATEGIES, 2017–2020

14 COMPANY PROFILES (Page No. - 267)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     14.1 THERMO FISHER SCIENTIFIC, INC.
               FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
     14.2 MERCK KGAA
               FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2019)
     14.3 EUROFINS SCIENTIFIC SE
               FIGURE 36 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2019)
     14.4 GE HEALTHCARE
               FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
     14.5 COVANCE, INC.
               FIGURE 38 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
     14.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
               FIGURE 39 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
     14.7 SGS S.A.
               FIGURE 40 SGS S.A.: COMPANY SNAPSHOT (2019)
     14.8 BIO-RAD LABORATORIES, INC.
               FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
     14.9 QIAGEN N.V.
               FIGURE 42 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
     14.10 CYPROTEX PLC
               FIGURE 43 EVOTEC AG: COMPANY SNAPSHOT (2019)
     14.11 PROMEGA CORPORATION
     14.12 CATALENT, INC.
                       FIGURE 44 CATALENT, INC.: COMPANY SNAPSHOT (2019)
     14.13 GENTRONIX LIMITED
     14.14 MB RESEARCH LABORATORIES
     14.15 BIOIVT
     14.16 CREATIVE BIOLABS
     14.17 GVK BIOSCIENCES PRIVATE LIMITED
     14.18 SHANGHAI MEDICILON INC.
     14.19 CREATIVE BIOARRAY
     14.20 INSPHERO

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 RELATED MARKETS (Page No. - 330)
     15.1 INTRODUCTION
     15.2 IN VIVO TOXICOLOGY MARKET
             15.2.1 MARKET DEFINITION
             15.2.2 LIMITATIONS
             15.2.3 MARKET OVERVIEW
                       FIGURE 45 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IN VIVO TOXICOLOGY MARKET DURING THE FORECAST PERIOD
     15.3 IN VIVO TOXICOLOGY MARKET, BY PRODUCT
             15.3.1 CONSUMABLES
                       TABLE 292 IN VIVO TOXICOLOGY CONSUMABLES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
             15.3.2 INSTRUMENTS
                       TABLE 293 IN VIVO TOXICOLOGY INSTRUMENTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
     15.4 IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT
             15.4.1 IMMUNOTOXICITY
                       TABLE 294 IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
             15.4.2 SYSTEMIC TOXICITY
                       TABLE 295 IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
             15.4.3 CARCINOGENICITY
                       TABLE 296 IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
             15.4.4 GENOTOXICITY
                       TABLE 297 IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
             15.4.5 DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
                       TABLE 298 IN VIVO TOXICOLOGY MARKET FOR DEVELOPMENTAL AND REPRODUCTIVE TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
             15.4.6 OTHER TOXICOLOGY ENDPOINTS
                       TABLE 299 IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
     15.5 IN VIVO TOXICOLOGY MARKET, BY REGION
             15.5.1 NORTH AMERICA
                       TABLE 300 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION)
             15.5.2 EUROPE
                       TABLE 301 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION)
             15.5.3 ASIA PACIFIC
                       TABLE 302 APAC: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION)
             15.5.4 LATIN AMERICA
                       TABLE 303 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION)
             15.5.5 MIDDLE EAST & AFRICA
                       TABLE 304 MIDDLE EAST & AFRICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION)

16 APPENDIX (Page No. - 344)
     16.1 INSIGHTS OF INDUSTRY EXPERTS
     16.2 DISCUSSION GUIDE
     16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     16.4 AVAILABLE CUSTOMIZATIONS
     16.5 RELATED REPORTS
     16.6 AUTHOR DETAILS

In this report, the global market for in vitro toxicology testing was arrived at after data triangulation from two different approaches as mentioned below. After completion of each approach, a weighted average of the two approaches was taken on the basis of the level of assumptions used in each approach.

Secondary Research

This research study involved the use of widespread secondary sources; directories; databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global in vitro toxicity testing market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, key developments related to market, and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the in vitro toxicology testing market. Primary sources from the demand side include scientists/researchers from academic & research institutes and government & private laboratories.

Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics. A breakdown of the primary respondents is provided below:

In Vitro Toxicity Testing Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product and service segment along with the technology, toxicity endpoint & tests, industry, method, and region).

Data Triangulation

After arriving at the market size, the total in vitro toxicology testing market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the global in vitro toxicology testing market by product & service, technology, toxicity endpoint & test, industry, method, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall in vitro toxicology testing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the in vitro toxicology testing market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the global in vitro toxicology testing market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions, new product launches, expansions, collaborations, and R&D activities of the leading players in the in vitro toxicology testing market
  • To benchmark players within the in vitro toxicology testing market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific in vitro toxicology testing market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe in vitro toxicology testing market into Switzerland, Belgium, Russia, the Netherlands, and others
COVID-19

Get in-depth analysis of the COVID-19 impact on the In Vitro Toxicity Testing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the In Vitro Toxicity Testing Market

Request For Special Pricing
Report Code
BT 2373
Published ON
Aug, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In Vitro Toxicity Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home